AbstractThis article describes data related to a research article titled “The Busulfan Metabolite EdAG Irreversibly Glutathionylates Glutaredoxins” [1]. EdAG is an electrophilic GSH analog formed in vivo from busulfan, which is used in hematopoietic stem cell transplants. EdAG glutathionylates Glutaredoxins (Grx's) but not glutathione transferase A1-1 (GSTA1-1) in vitro. This article includes a complete NMR characterization of synthetic EdAG including homonuclear and heteronuclear correlation spectra. Also included are mass spectra of peptides from Grx's or GSTA1-1 that have cys residues that do not react with EdAG
The role of busulfan (Bu) metabolites in the adverse events seen during hematopoietic stem cell tran...
Supplementary material for: [https://doi.org/10.1039/c5sc04818d]Related to published version: [http:...
Supporting information for: [https://doi.org/10.1055/s-0032-1328301]Related to published version: [...
AbstractThis article describes data related to a research article titled “The Busulfan Metabolite Ed...
This article describes data related to a research article titled “The Busulfan Metabolite EdAG Irrev...
Gamma-Glutamyldehydroalanylglycine (EdAG) is a dethiolated, electrophilic metabolite of glutathione ...
Gamma-Glutamyldehydroalanylglycine (EdAG) is a dethiolated, electrophilic metabolite of glutathione ...
Gamma-Glutamyldehydroalanylglycine (EdAG) is a dethiolated, electrophilic metabolite of glutathione ...
Busulfan is a bifunctional alkylating agent that is used to treat mylogenous leukemia. The major eli...
Busulfan is an example of a drug eliminated through glutathione S-transferase (GST)-catalyzed conjug...
Busulfan is an example of a drug eliminated through glutathione S-transferase (GST)-catalyzed conjug...
Elimination of hydrogen sulfide from glutathione (GSH) converts a well known cellular nucleophile to...
Background: Busulfan, an alkylating agent administered prior to hematopoietic stem cell transplantat...
This Special Issue of Antioxidants on Glutathione (GSH) and Glutaredoxin (Grx) was designed to colle...
This Special Issue of Antioxidants on Glutathione (GSH) and Glutaredoxin (Grx) was designed to colle...
The role of busulfan (Bu) metabolites in the adverse events seen during hematopoietic stem cell tran...
Supplementary material for: [https://doi.org/10.1039/c5sc04818d]Related to published version: [http:...
Supporting information for: [https://doi.org/10.1055/s-0032-1328301]Related to published version: [...
AbstractThis article describes data related to a research article titled “The Busulfan Metabolite Ed...
This article describes data related to a research article titled “The Busulfan Metabolite EdAG Irrev...
Gamma-Glutamyldehydroalanylglycine (EdAG) is a dethiolated, electrophilic metabolite of glutathione ...
Gamma-Glutamyldehydroalanylglycine (EdAG) is a dethiolated, electrophilic metabolite of glutathione ...
Gamma-Glutamyldehydroalanylglycine (EdAG) is a dethiolated, electrophilic metabolite of glutathione ...
Busulfan is a bifunctional alkylating agent that is used to treat mylogenous leukemia. The major eli...
Busulfan is an example of a drug eliminated through glutathione S-transferase (GST)-catalyzed conjug...
Busulfan is an example of a drug eliminated through glutathione S-transferase (GST)-catalyzed conjug...
Elimination of hydrogen sulfide from glutathione (GSH) converts a well known cellular nucleophile to...
Background: Busulfan, an alkylating agent administered prior to hematopoietic stem cell transplantat...
This Special Issue of Antioxidants on Glutathione (GSH) and Glutaredoxin (Grx) was designed to colle...
This Special Issue of Antioxidants on Glutathione (GSH) and Glutaredoxin (Grx) was designed to colle...
The role of busulfan (Bu) metabolites in the adverse events seen during hematopoietic stem cell tran...
Supplementary material for: [https://doi.org/10.1039/c5sc04818d]Related to published version: [http:...
Supporting information for: [https://doi.org/10.1055/s-0032-1328301]Related to published version: [...